A 3-Week Inpatient Rehabilitation Programme Improves Body Composition in People with Cystic Fibrosis with and Without Elexacaftor/Tezacaftor/Ivacaftor Therapy
Nutrients · 2025
DOI: 10.3390/nu17152439 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Jana Koop und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Human Nutrition and Food Science, Kiel University, Düsternbrooker Weg 17, 24105 Kiel, Germany. Hauptthemen laut MEDLINE: Cystic Fibrosis, Body Composition, Quinolones, Aminophenols. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Rentenversicherung Nord, Schleswig-Holsteinische Vereinigung zur Bekämpfung der Tuberkulose und der Lungenkrankheiten e.V., Mukoviszidose Selbsthilfe e.V.
Abstract (Originalsprache)
Background
The introduction of cystic fibrosis transmembrane conductance regulator modulators, especially the triple therapy elexacaftor, tezacaftor, ivacaftor (ETI), has improved outcomes in people with cystic fibrosis (pwCF), reducing underweight but increasing overweight rates.
Objectives
This study investigates the effect of ETI on appetite control, body composition, and energy balance during a 3-week inpatient rehabilitation programme with regular exercise.
Methods
In 54 pwCF (38 on ETI, 16 without ETI), changes in body composition (fat mass index, FMI; fat-free mass index, FFMI) and energy balance (calculated from body composition changes) were assessed. Appetite control was evaluated via plasma peptide YY (PYY) levels and post-exercise meal energy intake.
Results
The programme significantly increased BMI (+0.3 ± 0.1 kg/m2; CI 0.1–0.4) and energy balance (+4317 ± 1976 kcal/3 weeks), primarily through FFMI gains (+0.3 ± 0.1 kg/m2; CI 0.1–0.4). Despite higher post-exercise meal energy intake and a tendency towards lower PYY levels in the ETI group, changes in body composition and energy balance did not differ between groups. This is explained by a higher prevalence of exocrine pancreatic insufficiency in the ETI group (92% vs. 50%, p < 0.001). Small sample sizes limit the interpretation of data on appetite control and energy intake.
Conclusions
A 3-week inpatient rehabilitation programme improved body composition in pwCF, without resulting in a more positive energy balance with ETI therapy. This is due to a higher prevalence of pancreatic insufficiency in this group.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Human Nutrition and Food Science, Kiel University, Düsternbrooker Weg 17, 24105 Kiel, Germany.
- Pediatric Pulmonology and Sleep Medicine, Cystic Fibrosis Center, Children's Hospital, University of Duisburg-Essen, Hufelandstrasse 55, 45122 Essen, Germany.
- Department of Nutrition and Gerontology, German Institute of Human Nutrition Potsdam-Rehbrücke, Arthur-Scheunert-Allee 114-116, 14558 Nuthetal, Germany.
- Department of Geriatrics and Medical Gerontology, Charité-Universitätsmedizin Berlin, Reinickendorfer Strasse 61-62, 13347 Berlin, Germany.
- Strandklinik St. Peter-Ording, Fritz-Wischer-Straße 3, 25826 St. Peter-Ording, Germany.
- Fachklinik Satteldüne DRV Nord, Tanenwai 32, 25946 Nebel, Germany.
ORCID-Profile: Jana Koop, Wolfgang Gruber, Mario Hasler, Anja Bosy-Westphal
Förderung
- Deutsche Rentenversicherung Nord
- Schleswig-Holsteinische Vereinigung zur Bekämpfung der Tuberkulose und der Lungenkrankheiten e.V.
- Mukoviszidose Selbsthilfe e.V
- Mukoviszidose Selbsthilfe e.V., Dessau-Roßlau, Germany
Zitieren
APA
Koop, J., Gruber, W., Hägele, F. A., Norman, K., Herpich, C., Dewey, S., Falkenberg, C., Schnabel, O., Weisser, B., Hasler, M., & Bosy-Westphal, A. (2025). A 3-Week Inpatient Rehabilitation Programme Improves Body Composition in People with Cystic Fibrosis with and Without Elexacaftor/Tezacaftor/Ivacaftor Therapy. Nutrients. https://doi.org/10.3390/nu17152439
Vancouver
Koop J, Gruber W, Hägele FA, Norman K, Herpich C, Dewey S, et al. A 3-Week Inpatient Rehabilitation Programme Improves Body Composition in People with Cystic Fibrosis with and Without Elexacaftor/Tezacaftor/Ivacaftor Therapy. Nutrients. 2025. doi:10.3390/nu17152439
BibTeX
@article{Koop2025,
author = {Koop, Jana and Gruber, Wolfgang and Hägele, Franziska A and Norman, Kristina and Herpich, Catrin and Dewey, Stefan and Falkenberg, Christian and Schnabel, Olaf and Weisser, Burkhard and Hasler, Mario and Bosy-Westphal, Anja},
title = {A 3-Week Inpatient Rehabilitation Programme Improves Body Composition in People with Cystic Fibrosis with and Without Elexacaftor/Tezacaftor/Ivacaftor Therapy},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17152439}
}
EUVIMED